The positive correlation between BDNF and post-baseline cognition among AYA cancer patients in our study contributes additional evidence to the literature that higher plasma BDNF levels may indicate resilience against treatment-induced neural damage through its physiological role in regulating neural growth and plasticity20. This evidence concerns the gene BDNF and cancer.